Immune Restoration / Immune Recovery

Starting HAART with a Higher CD4 Cell Count Improves Immune Recovery and Reduces the Risk of Disease Progression or Death - 8/31/07

Protease Inhibitor and PI-sparing Regimens Provide Similar Levels of Long-term Immune Reconstitution in Patients with Low CD4 Cell Counts   - 8/17/07

Risk of TB-associated Immune Reconstitution Disease Is High in South African Patients Initiating Antiretroviral Therapy with Low Baseline CD4 Cell Counts  - 3/16/07

CD4+ T Cell Recovery and Reconstitution of Gut Tissue In AIDS Patients Treated with Viramune plus Trizivir  - 3/09/07

Lopinavir/Ritonavir Produces Durable Immunological Recovery in HAART-experienced Patients  1/05/07

Treatment of HIV-associated Kaposi's Sarcoma with Pegylated Liposomal Doxorubicin and HAART Produces Tumor Remission and CD4+ T Cell Recovery - 10/26/05

HAART Produces Significant Immune Reconstitution Even in Children Who Do Not Reach Undetectable Viral Loads or Who Have Viral Load Rebound - 6/20/05

Immunological Changes after HAART with Lopinavir-Ritonavir in Heavily Pretreated Children - 6/08/05

48-week Efficacy of Once-daily Saquinavir Soft-gel/Ritonavir in Patients with Undetectable Viral Load after 3 Years of Antiretroviral Therapy - 4/06/05